Singapore, April 9 -- The global medtech landscape is undergoing a seismic shift, largely driven by the meteoric rise of Chinese companies. For decades, the narrative was simple: China made things cheaply. That story is now dangerously outdated. Today, Chinese medtech firms are not just competing; they are increasingly setting the pace in innovation, quality, and global reach.

China's role in international medtech trade has expanded significantly. In 2000, the country accounted for less than 3% of global trade in medtech products. By 2021, China's share had surged to 12.4% of global exports - amounting to nearly $40 Billion.

China's medical device market has grown significantly, reinforcing its position as a global manufacturing leader....